BiotechTube
Home/Protara Therapeutics/Julianne Averill
JA

Julianne Averill

Chief Financial Officer & Chief Operating Officer

Protara Therapeutics

Therapeutic Areas

OncologyRare Diseases

Protara Therapeutics Pipeline

DrugIndicationPhase
TARA-002Non-Muscle Invasive Bladder Cancer (NMIBC), BCG-unresponsive Carcinoma In Situ (CIS)Phase 2
IV Choline ChlorideIntestinal Failure-Associated Liver Disease (IFALD)Phase 2

Leadership Team at Protara Therapeutics

JS
Jesse Shefferman
Chief Executive Officer
BR
Blaine Rath
Executive Vice President, General Counsel & Corporate Secretary
HC
Hannah Chism
Executive Vice President, Clinical Development
RH
Richard H. Steinhart
Chairman of the Board
View full Protara Therapeutics profile